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Genetic studies in a range of organisms reveal that essential
transcription factors (TFs) tend not only to be conserved in
sequence but also in function. For example, the NKx2.5 TFs are
essential for heart development in species as diverse as mice
[1], zebrafish [2], Xenopus [3], humans [4] and Drosophila [5].
At a structural level, the DNA-binding domains of many
orthologous TFs are highly similar over large evolutionary
distances, allowing them to bind to identical DNA motifs. In
fact, cross-species experiments demonstrate that ortholo-
gous TFs can regulate the same target genes and even rescue
some mutant phenotypes [6,7]. It is thus reasonable to
assume that conserved TFs, which lead to the development
and maintenance of orthologous tissues [8], regulate con-
served sets of downstream target genes as part of conserved
gene-regulatory networks.
It therefore came as a surprise when recent studies on DNA
binding of the TFs Zeste among Drosophila species [9] and
Ste12 and Tec1 across yeast species [10] indicated that
individual binding events turn over rapidly during evolution.
A similar discovery has been made for liver-specific TFs
among vertebrates [11]. Mouse and human hepatocytes have
a similar complement of gene expression [11] and are
defined by a set of highly conserved TFs [8], yet the under-
lying  cis-regulatory network appears to have diverged
extensively. Odom et al. [11] showed that relatively few TF-
binding events - perhaps even a small minority in some
cases - are conserved between the two species. Their results
indicate that the target genes of hepatocyte TFs differ
significantly from mouse to human, and even when
orthologous genes are targeted by the same TF, the exact
pattern of binding events at the conserved DNA motifs is
different. These results, together with those from Drosophila
and yeast, argue that binding events are subject to less
selective pressure than previously anticipated, which has
important implications for the degree of divergence in cis-
regulatory networks.
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Despite the high conservation of the TFs assayed in the
studies mentioned above, it is conceivable that the differ-
ences in binding signatures between species were due to
differential interaction with cofactors (owing to differences
in protein-protein interactions or cofactor availability), other
species-specific nuclear conditions, or simply because of
experimental variables. Alternatively, the genomic sequences
themselves might be different enough to trigger species-
specific TF-binding signatures. A new study by Wilson et al.
[12] addresses precisely this question by using a mouse
model for human trisomy 21. This partially mosaic ‘Tc1’
mouse line carries most of human chromosome 21 in
addition to the entire murine chromosome complement [13].
Assaying TF binding to both the mouse and human chromo-
somes in the same cells eliminates many technical variables,as well as variables pertaining to interspecies differences in
nuclear environment. Importantly, all assayed TFs are
derived from the mouse genome, as none of them, nor any
known cofactors or other hepatocyte-specific factors, are
encoded on human chromosome 21 [12]. The authors were
therefore able to ask: ‘Does a human chromosome in the
murine nuclear context exhibit human-like, mouse-like, or a
mixture of TF binding signatures?’ In other words, does the
human genetic material direct where TFs bind, or do mouse
TFs bind elsewhere - maybe even to sites orthologous to the
cognate mouse chromosome sites?
The authors focus on the binding events exhibited by three
hepatocyte-specific TFs (HNF1a, HNF4a, and HNF6) across
the orthologous regions of human chromosome 21 (WT-
HsChr21) in human liver tissue, human chromosome 21 in
mice (Tc1-HsChr21) and mouse chromosome 16 (Tc1-
MmChr16) [12]. Only about a third to a half of identified
bound regions are shared among all three chromosomes,
confirming the stark differences in TF-binding events
between mouse and human observed previously [11]. Impor-
tantly, the vast majority of the remaining peaks on human
chromosome 21 are not found on the mouse chromosome,
but rather recapitulate peaks found on chromatin isolated
from human liver tissue [12]. The fact that mouse TFs, in the
mouse nuclear environment, still recapitulate human-like
binding signatures on a human-derived chromosome
strongly indicate that it is the human chromosomal sequence
that is primarily responsible for the placement of trans-
cription factors (cis-directed), rather than changes in the
regulators or the regulative environment (trans-directed). It
is interesting to note that a small number of peaks (5 out of
173 non-shared peaks) appear to be trans-directed (Tc1-
HsChr21 peaks align with Tc1-MmChr16 peaks), and may
warrant further investigation in their own right.
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Having established that the TFs are placed on the DNA in a
species-specific sequence-dependent manner, the authors
examined an event downstream of TF recruitment - the place-
ment of the basal transcriptional machinery. They did this by
chromatin immunoprecipitation followed by microarray
analysis (ChIP-chip) against the trimethylated state of lysine 4
on histone H3 (H3K4me3) [14]. Whereas the majority of the
H3K4me3 peaks detected can be identified in equivalent
positions on human chromosome 21 and the corresponding
mouse regions, some of these methylation marks appear
species-specific, as indicated previously [15].
In Tc1 mice, the authors report 78 alignable H3K4me3
marks, of which about two-thirds (53) are shared between
mouse and human. Of the remaining 25 peaks, 18 Tc1-
HsChr21 peaks were also found on the WT-HsChr21 (cis-
directed, mostly not at transcriptional start sites (TSSs)),
indicating that the human chromosomal sequence plays a
significant (albeit not necessarily direct) role in the
placement of at least some epigenetic marks [12]. Curiously,
the remaining seven H3K4me3 marks appear trans-directed
(also found on Tc1-MmChr16, mostly at TSSs) and may
represent cases where human chromosomal regions are
recognized and treated by the mouse nuclear environment in
a mouse-specific manner. Finally, the authors find that the
transcriptional profile of human chromosome 21 genes in
Tc1 mice resembles their transcription in the native human
environment, rather than the transcriptional profile of their
murine orthologs [12].
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Studies of cis-evolution have largely focused on individual
enhancers or cis-regulatory modules (CRMs) [16-19]; however,
more recent studies venture to identify cis-regulatory differ-
ences on a global scale [10,11,20]. The use of the trans-
chromosomic Tc1 mice [12] to address species-specific
differences in transcriptional regulation is certainly elegant,
and one wonders if, in principle, a similar system might be
extendable to other chromosomes, transcription factors,
tissues, developmental contexts and species.
The study by Wilson et al. [12] provides strong evidence that
it is the genomic sequence, rather than differences in nuclear
environment, which is primarily responsible for the differ-
ences in mouse versus human TF occupancy. This under-
lines the importance of measuring TF binding directly rather
than inferring occupancy through sequence and phylo-
genomic analysis. The ability of murine hepatocyte TFs to
‘read’ the transcriptional program of a human chromosome,
even when placed in the nuclear environment of the mouse,
a species separated from humans by approximately 75-100
million years, adds to the growing evidence that cis-regula-
tory changes are a major (if not the) driving force of
evolutionary change [21].
As with all interspecies comparisons, the conclusions that
can be drawn from these studies are largely dependent on
reliable alignment of the genomes and the faithful mapping
of orthologous regions [22]. For example, misalignment of
ChIP peaks will skew data, as orthologous peaks could easily
be misannotated as trans-, rather than cis-directed. The task
of sequence alignment is relatively tractable when per-
forming interspecies comparisons of coding regions, but the
challenge is exponentially more difficult when comparing
noncoding regions. Even with largely syntenic chromosomes
(such as mouse chromosome 16 versus human chromosome
21), defining orthologous peaks is very difficult. Choosing
the proper species for cross-species analyses is extremely
important and depends on the precise question being asked
(for example, [17]): whereas comparisons over large evolu-
tionary distances might yield insights into gross changes in
gene regulatory networks [10,12], comparisons over smaller
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in the underlying cis-regulatory networks [9,16].
One important remaining question from the hepatocyte
studies [11,12] concerns the functional activity of species-
specific TF binding. Although the authors show by Solexa
sequencing that most of the species-unique H3K4me3 marks
are associated with transcription, a precise analysis of the
overlap of TF-bound regions with regions of active trans-
cription (deduced from either H3K4me3 marks or expres-
sion profiling) was not presented. Do the genomic regions
bound in both human and mouse correspond to regulatory
regions in the vicinity of active transcription (that is, in close
proximity to shared H3K4me3 peaks), whereas uniquely
bound regions do not? In other words, do conserved binding
events represent the functional sites? If this is the case, it
suggests that once ‘functional’ cis-binding events are
distilled from non-functional ones, there may be significant
conservation in cis-regulatory networks. Alternatively,
although the general properties of gene regulatory networks
are conserved, the underlying cis-regulatory networks may
have undergone significant divergence. No doubt future cis-
evolutionary studies, both at individual loci and genome-
wide, will begin to unravel this question and provide exciting
insights into the general principles underlying the changes
in cis-regulatory networks during speciation.
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